AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
65 hedge funds and large institutions have $60.4M invested in AVEO Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
1% less call options, than puts
Call options by funds: $6.32M | Put options by funds: $6.35M
Holders
65
Holding in Top 10
–
Calls
$6.32M
Puts
$6.35M
Top Buyers
| 1 | +$6.02M | |
| 2 | +$880K | |
| 3 | +$572K | |
| 4 |
Renaissance Technologies
New York
|
+$552K |
| 5 |
State Street
Boston,
Massachusetts
|
+$500K |
Top Sellers
| 1 | -$5.94M | |
| 2 | -$398K | |
| 3 | -$235K | |
| 4 |
Jane Street
New York
|
-$213K |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$149K |